netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 11: Eye - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

 Details...
11.99.99.99  Expand sub section  Miscellaneous
Adalimumab injection (uveitis)
View adult BNF View SPC online
Formulary
Red
High Cost Medicine
BlueTeq

Approved for treating non-infectious uveitis as per NICE TA460

 
Link  NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis
   
Rituximab injection (neuromyelitis optica - off-label)
View adult BNF View SPC online
Formulary
Red
High Cost Medicine

Approved off-label indication:

Neuromyelitis optica as per NHS England service specification D04/S(HSS)/b

Category B* form required

First 2 courses given and funded by NHS England commissioned centres. If ongoing care is needed it may be given locally via local funding

Biosimilar products available, to be prescribed by brand name.

Contact pharmacy department for advice on brand for routine prescribing if unsure

 
Link  NHSE D04/S(HSS)/b: Neuromyelitis optica service (adults and children)
   
EDTA eye drops 0.37% (Disodium edetate)
View adult BNF View SPC online
Formulary
Red
Approved for the following indication:
  • Chelating agent in calcific band keratopathy  
  •    
    Acetylcysteine eye drops 10%
    Unlicensed Drug Unlicensed Dry eye associated with increased mucous production 
       
    Acetylcysteine preservative-free eye drops 5%
    Unlicensed Drug Unlicensed Dry eye associated with increased mucous production 
       
    EDTA eye drops 0.37% (Disodium edetate)
    Unlicensed Drug Unlicensed
    Red
    Approved for the following indication:
  • Chelating agent for chemical burns to eye  
  •    
    Healonid GV injection
    Unlicensed Drug Unlicensed

    Corneal endothelial protection

     
       
    Miraflow cleaning solution
    Unlicensed Drug Unlicensed Contact lens cleaner 
       
    Cytotoxic Drug Mitomycin eye drops 0.04%
    Unlicensed Drug Unlicensed
    Red
    Prevention of scar tissue formation following glaucoma filtering surgery 
       
    Mydricaine ampoule No. 2
    Unlicensed Drug Unlicensed
    Red

    ADULT USE ONLY

    Contains:

    • Procaine hydrochloride
    • Atropine sulphate
    • Adrenaline Mydriatic given by subconjunctival injection prior to vitroretinal surgery
     
       
    Perfluoro-N-Octane injection
    Unlicensed Drug Unlicensed Aid to ocular surgery 
       
    Potassium ascorbate eye drops
    Unlicensed Drug Unlicensed Chemical burns to eye 
       
    Sodium citrate eye drops 10.11%
    Unlicensed Drug Unlicensed
    Red
    Chemical burns to eye 
       
     ....
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to SPCs
    SMC
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Red

    Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

    Amber 1

    Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

    Amber 2

    Specialist initiation followed by maintenance prescribing in primary care  

    Amber 3

    Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

    Green

    Specialist and non-specialist initiation  

    Grey

    Not recommended for prescribing  

    netFormulary